Welcome to our dedicated page for MARSH & MCLENNAN COMPANIES SEC filings (Ticker: MRSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MARSH & MCLENNAN COMPANIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MARSH & MCLENNAN COMPANIES's regulatory disclosures and financial reporting.
Marsh & McLennan Companies executive Nicholas Mark Studer reported equity awards rather than open‑market trades. He received stock options covering 21,129 shares of Marsh & McLennan common stock at an exercise price of $0.0000 per share. These options were granted on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
He was also granted 8,044 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period. The performance factor for these units was determined on February 24, 2026, and both the options and units convert into Marsh & McLennan common stock on a 1‑for‑1 basis.
Marsh & McLennan Companies Vice President and Controller Stacy Mills reported equity awards that increase her direct incentive stake in the company. On February 24, 2026, she was granted stock options for 3,574 shares at a price of $0.00 per share.
These options vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030 and convert into common stock on a 1-for-1 basis. On the same date, she also acquired restricted stock units of 1,342 and 1,625 shares under prior and new awards, with the earlier grant tied to 2023–2025 performance and the newer grant vesting in three equal installments on February 28 of 2027, 2028 and 2029.
Marsh & McLennan Companies executive Patrick Tomlinson, President and CEO of Mercer, reported new equity awards. He received 28,586 stock options that were granted on February 24, 2026 and will vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
Tomlinson was also granted 1,609 restricted stock units tied to performance stock units originally awarded on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026. Both instruments convert into Marsh & McLennan common stock on a 1-for-1 basis.
Marsh & McLennan Companies, Inc. has appointed Peter Harrison, age 59, as an independent member of its board of directors, effective February 25, 2026. With his addition, the Board now consists of 13 directors.
Harrison brings more than three decades of investment management and executive leadership experience, including serving as CEO of Schroders plc and senior roles at RWC Partners and Deutsche Bank’s asset management businesses. He currently chairs Morgan Sindall plc’s board and serves on Lazard, Inc.’s board, alongside multiple industry and community leadership roles.
Marsh & McLennan Companies, Inc. issued $600 million aggregate principal amount of 4.950% Senior Notes due 2036. The notes were purchased by an underwriting group led by Citigroup Global Markets, J.P. Morgan Securities and Wells Fargo Securities under an underwriting agreement dated February 11, 2026.
The notes were issued under Marsh & McLennan’s existing base indenture dated July 15, 2011, as supplemented by a Twenty-First Supplemental Indenture dated February 19, 2026. They were registered on the company’s effective Form S-3 shelf registration statement and offered using a base prospectus and a dated prospectus supplement.
Marsh & McLennan Companies director Morton O. Schapiro reported compensation-related equity activity in company stock units. He acquired 237.74 restricted stock units on February 15, 2026 as a grant, and 456.03 units on February 13, 2026 through dividend equivalents and director fees under the Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis.
Marsh & McLennan Companies director Anthony Anderson reported administrative updates to his equity holdings. On February 13, 2026, an entry labeled as an “other” transaction involved 80.98 restricted stock units under the Directors Stock Plan, tied to a reference price of $172.98 per unit.
Footnotes explain these restricted stock units accrue from dividend equivalents and convert into common stock on a 1-for-1 basis. Following these updates, Anderson reported 15,644.66 restricted stock units and 2,014.102 common shares held directly. The activity reflects plan-related credits rather than open-market buying or selling.
MARSH & MCLENNAN COMPANIES director Deborah C. Hopkins reported an administrative equity adjustment. On February 13, 2026, she had 103.28 restricted stock units credited to her account as dividend equivalents under the Directors Stock Compensation Plan. These restricted stock units convert into common stock on a 1-for-1 basis, bringing her directly held restricted stock unit balance to 19,952.92 units following the transaction.
Marsh & McLennan Companies director Tamara Ingram reported an automatic increase in equity-based compensation. She received 39.82 restricted stock units as dividend equivalents under the company’s Directors Stock Compensation Plan, each convertible into one share of common stock, bringing her directly held restricted stock units to 7,693.42.
MARSH & MCLENNAN COMPANIES director Lloyd M. Yates reported stock-based compensation activity involving restricted stock units that convert into common shares on a 1-for-1 basis. On February 15, he received 208.92 restricted stock units at a reference price of $173.51 per unit as a grant under the Directors Stock Compensation Plan. On February 13, an additional 54.59 restricted stock units at $172.98 per unit were credited as dividend equivalents and director fee-related awards. Following these transactions, his directly held restricted stock units totaled 10,755.18.